MEDICINOVA INC (MNOV)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, MEDICINOVA INC reported revenue of $409.7K. The company ran a net loss, with a net margin of -2928.8%. It held $45.60M in total assets against $4.02M in total liabilities.
Key ratios (FY2025)
-3242.5%
Operating margin
-2928.8%
Net margin
-28.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $409.7K | — | $1.00M | — | $4.04M | — | — | — | — | — |
| Operating Income | -$13.28M | -$12.68M | -$9.90M | -$14.63M | -$10.22M | -$14.18M | -$14.03M | -$15.59M | -$13.03M | -$10.88M |
| Net Income | -$12.00M | -$11.05M | -$8.57M | -$14.07M | -$10.13M | -$13.85M | -$12.94M | -$14.68M | -$11.16M | -$10.87M |
| EPS (Diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | — | — | — | — | — |
| Total Assets | $45.60M | $55.88M | $66.27M | $74.15M | $87.41M | $75.42M | $79.21M | $77.22M | $43.42M | $39.81M |
| Total Liabilities | $4.02M | $3.37M | $3.89M | $3.91M | $3.73M | $4.09M | $4.31M | $4.12M | $4.78M | $5.28M |
| Shareholders' Equity | $41.59M | $52.50M | $62.38M | $70.24M | $83.68M | $71.33M | $74.89M | $73.11M | $38.64M | $34.53M |
| Cash & Equivalents | $30.81M | $40.36M | $51.00M | $18.51M | $71.43M | $60.04M | $63.79M | $62.31M | $27.99M | $24.12M |
| Operating Cash Flow | -$9.81M | -$10.64M | -$7.43M | -$12.91M | -$9.38M | -$10.83M | -$9.12M | -$9.11M | -$6.92M | -$6.55M |
| Capital Expenditures | $2.9K | $895 | $21.3K | $5.0K | $28.7K | $36.5K | $11.3K | $10.2K | — | $84.5K |
| Shares Outstanding | 49.22M | 49.05M | 49.05M | 49.05M | 49.04M | 45.02M | 43.91M | 42.08M | 36.45M | 34.52M |